154 related articles for article (PubMed ID: 15883134)
1. Shortening the stent length reduces restenosis with bare metal stents: matched pair comparison of short stenting and conventional stenting.
Dietz U; Holz N; Dauer C; Lambertz H
Heart; 2006 Jan; 92(1):80-4. PubMed ID: 15883134
[TBL] [Abstract][Full Text] [Related]
2. Short stent implantation for routine use is feasible in a high proportion of coronary interventions and yields a low restenosis rate.
Dietz U; Holz N; Dauer C; Meinert R; Lambertz H
Cardiology; 2005; 103(4):212-8. PubMed ID: 15838166
[TBL] [Abstract][Full Text] [Related]
3. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
[TBL] [Abstract][Full Text] [Related]
4. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
[TBL] [Abstract][Full Text] [Related]
5. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
[TBL] [Abstract][Full Text] [Related]
6. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
7. Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient.
Ruygrok PN; Webster MW; Ardill JJ; Chan CC; Mak KH; Meredith IT; Stewart JT; Ormiston JA; Price S
Catheter Cardiovasc Interv; 2003 Jun; 59(2):165-71. PubMed ID: 12772233
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
[TBL] [Abstract][Full Text] [Related]
10. Elective stenting in small coronary arteries: results of the Italian prospective multicenter registry MICROSCOPE.
Airoldi F; Di Mario C; Presbitero P; Maiello L; Carcagnì A; Bortone A; Cremonesi A; Castriota F; Frasheri A; Rubino A; Pernice V; Rubartelli P; Reimers B; Colombo A
Ital Heart J; 2002 Jul; 3(7):406-11. PubMed ID: 12189969
[TBL] [Abstract][Full Text] [Related]
11. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study.
Rodriguez AE; Granada JF; Rodriguez-Alemparte M; Vigo CF; Delgado J; Fernandez-Pereira C; Pocovi A; Rodriguez-Granillo AM; Schulz D; Raizner AE; Palacios I; O'Neill W; Kaluza GL; Stone G;
J Am Coll Cardiol; 2006 Apr; 47(8):1522-9. PubMed ID: 16630986
[TBL] [Abstract][Full Text] [Related]
12. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
Tan HC; Lim YT; Rosli TL; Sim KH; Tan KH; Lee CH; Ismail O; Azman W
Am Heart J; 2004 Dec; 148(6):1007-11. PubMed ID: 15632886
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
Chen WH; Kaul U; Leung SK; Lau YK; Tan HC; Leung AW; Lee MK; Li SK; Ng W; Lee PY; Lam KF; Tse HF; Lau CP
J Invasive Cardiol; 2005 Oct; 17(10):534-8. PubMed ID: 16204748
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy of low- (80 mg/day) and high- (160-320 mg/day) dose valsartan in the prevention of in-stent restenosis after implantation of bare-metal stents in type B2/C coronary artery lesions.
Peters S
Am J Cardiovasc Drugs; 2008; 8(2):83-7. PubMed ID: 18422391
[TBL] [Abstract][Full Text] [Related]
17. The RESTART project: high-dose atorvastatin helps control RESTenosis AfteR sTenting procedures at high risk for restenosis. Results from a prospective study and a matched control group comparison.
Prati F; Imola F; Corvo P; Cernigliaro C; Fouadi T; Ramazzotti V; Manzoli A; Pappalardo A; Cera M
EuroIntervention; 2007 May; 3(1):89-94. PubMed ID: 19737690
[TBL] [Abstract][Full Text] [Related]
18. Results of the quantitative coronary angiographic analysis in the angiographic subgroup of the Multi-Link 2.5 Portuguese Registry.
Seabra-Gomes R; Almeida M; Cavaco D; Bettencourt V; Baptista J; Marques AL; Pereira H; Farto e Abreu P; dos Santos LP
Rev Port Cardiol; 2001 Sep; 20(9):841-55. PubMed ID: 11763596
[TBL] [Abstract][Full Text] [Related]
19. Low restenosis rate of the NIR coronary stent: results of the Danish multicenter stent study (DANSTENT)--a randomized trial comparing a first-generation stent with a second-generation stent.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Madsen JK; Kløvgaard L; Thuesen L; Villadsen A; van Weert AW; Reiber JH;
Am Heart J; 2003 Feb; 145(2):e5. PubMed ID: 12595860
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings.
Hoffmann R; Herrmann G; Silber S; Braun P; Werner GS; Hennen B; Rupprecht H; vom Dahl J; Hanrath P;
Am J Cardiol; 2002 Sep; 90(5):460-4. PubMed ID: 12208402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
